SCHEMBL29901275

SCHEMBL29901275

N#Cc1c(Cl)nc2cnc(C3CC3)cc2c1Cl

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE9A O76083 2/20 0.38
▸ ALDH1A1 P00352 6/20 0.34
▸ HPGD P15428 6/20 0.34
▸ KDM4E B2RXH2 5/20 0.34
▸ MEN1 O00255 3/20 0.34
▸ KMT2A Q03164 3/20 0.34
▸ TSHR P16473 3/20 0.34
▸ HSD17B10 Q99714 3/20 0.34
▸ MAPT P10636 2/20 0.34
▸ NPSR1 Q6W5P4 1/20 0.34
▸ ADORA2A P29274 1/20 0.33
▸ ADORA1 P30542 1/20 0.33
▸ GAA P10253 3/20 0.32
▸ LMNA P02545 3/20 0.32
▸ L3MBTL1 Q9Y468 2/20 0.32
▸ TDP1 Q9NUW8 1/20 0.32
▸ MAPK1 P28482 2/20 0.32
▸ NSD2 O96028 1/20 0.32
▸ S1PR1 P21453 2/20 0.31
▸ TP53 P04637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22274905 1.00 PDE9A (0.38) PDE9AALDH1A1HPGDKDM4EMEN1
SCHEMBL24203389 0.86 ALDH1A1 (0.38) PDE9AALDH1A1HPGDKDM4EMEN1
SCHEMBL21840082 0.74 KMT2A (0.36) PDE9AALDH1A1HPGDKDM4EMEN1
SCHEMBL29901239 0.74 PDE9A (0.50) PDE9A
SCHEMBL22274912 0.73 PDE9A (0.37) PDE9AALDH1A1L3MBTL1MAPK1HTT
SCHEMBL20870600 0.73 RECQL (0.38) PDE9AALDH1A1HPGDKDM4EMEN1
SCHEMBL29901256 0.72 PDE9A (0.62) PDE9A
SCHEMBL22274904 0.72 PDE9A (0.62) PDE9A
SCHEMBL22274911 0.71 HTT (0.31) L3MBTL1HTT
SCHEMBL29901261 0.71 HTT (0.31) L3MBTL1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111471059-B PDE9 inhibitors and uses thereof 药捷安康(南京)科技股份有限公司 2022-12-02 — — CN disclosed
CN-111658653-B Use of phosphodiesterase inhibitors 药捷安康(南京)科技股份有限公司 2022-09-09 — — CN disclosed
Send feedback